相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
Hamartin (TSC1)
- 级别:
Hamartin (TSC1) Antibody
- 目录编号:
Hamartin (TSC1) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
Hamartin (TSC1) Antibody
- 抗体英文名:
Purified anti-Hamartin (TSC1) Antibody
- 抗体名:
Hamartin (TSC1) Antibody
- 标记物:
Hamartin (TSC1) Antibody
- 宿主:
小鼠
- 适应物种:
人、小鼠
- 免疫原:
Hamartin (TSC1) Antibody
- 亚型:
Hamartin (TSC1) Antibody
- 形态:
Hamartin (TSC1) Antibody
- 应用范围:
WB
- 保存条件:
2-8℃
- 浓度:
0.5 mg/ml
- 规格:
100 µg
Description :Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that is due toinactivating mutations in TSC1 (also known as hamartin) or TSC2 (also known as tuberin). TSCis featured by benign tumors (hamartomas) involving multiple organ systems. TSC1, TSC2 andTBC1 domain family member 7 (TBC1D7) form the TSC protein complex that acts as aninhibitor of the mechanistic target of rapamycin (mTOR) signaling, which in turn plays a criticalrole in regulating cell growth, proliferation, autophagy and protein and lipid synthesis. The TSCprotein complex controls the activity of mTORC1 via RAS homologue enriched in brain (RHEB).mTORC1 downstream targets include phospho‑p70 ribosomal S6 kinase, phospho-ribosomalprotein S6 and phospho‑4EBP1 (eukaryotic translation initiation factor 4E‑binding protein 1).Activation of mTORC1 enhances protein translation, and hyperactivation of mTORC1 has beendiscovered to lead to extensive metabolic reprogramming, including effects on glycolysis,autophagy, nucleotide biosynthesis and lipid biosynthesis. In many cases, this reprogrammingleads to vulnerabilities that induce cell death indicating that the altered metabolism of cells withmTORC1 hyperactivation will provide therapeutic opportunities. By contrast, inhibition ofmTORC1 with allosteric inhibitors, such as sirolimus and everolimus, restores TSC2‑deficientcells to metabolic homeostasis and may thereby ‘protect’ them from cell death.
In addition to the canonical TSC–RHEB–mTORC1 pathway, there is evidence of non-canonicalpathways. These include targets of TSC1 that are TSC2 independent, targets of TSC1 andTSC2 that are RHEB independent and targets of RHEB that are mTORC1 independent.
Verified Reactivity :Human, Mouse
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :Partial human TSC1 recombinant protein (480-666 a.a.)
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C.
Application :WB - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by Western blotting. For Western blotting, thesuggested use of this reagent is 0.5 - 5.0 µg per ml. It is recommended that the reagent be titratedfor optimal performance for each application.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验c.两只山羊,每只均经过四次免疫 d.1,000~1,200ml抗血清 e.Protein G亲和纯化100ml抗血清 f.ELISA测试 A.2~5ml免疫前血清 B.ELISA结果 C.100ml抗血清中经Purified G纯化的抗体 C.≈1000ml抗血清 E.5mg未偶联多肽,MS和HPLC报告
培养箱中培养。 2、实验结果 图:1×10^6/孔细胞,5μg anti-mouse CD3与CD28刺激3天后细胞形成明显克隆团 CD3/CD28 Streptamer® 多聚体法 1、实验原理 使用低亲和力的抗 CD3 和抗CD28的抗体 Fab 片段(非传统全长抗体),结合上 Twin-Strep-tag 亲和标签,形成 CD3 Fab-Strep 和 CD28 Fab-Strep。再结合可溶性蛋白多聚体 Strep-Tactin®,在亲和力作用下,即可与 TCR 和 CD28 共刺激
我是用来做筛选IgG型单克隆抗体,用它做二抗,筛到的阳性克隆化和扩大培养后用SIGMA亚类试剂盒鉴定却是IgM,郁闷!!!这个试剂盒能与IGM交叉?是不是抗轻链?我这种方式不对吗?谁知道有较好的抗鼠IgG而与IgM不交叉的抗体?? 试剂盒说明书:Anti-mouse IgG-HRP Antibody FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS. R&D Systems, Inc. 1-800-343-7475 2/21/06










